Recombinant Human Thrombopoietin（rhTPO）

DRUG2 trials

Sponsors

Institute of Hematology & Blood Diseases Hospital, China

Conditions

Hematopoietic Stem Cell MobilizationPrimary Immune Thrombocytopenia (ITP)

Unknown Phase

Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia

Not yet recruitingNCT06955858

Institute of Hematology & Blood Diseases Hospital, ChinaHematopoietic Stem Cell Mobilization

Start: 2025-05-30End: 2026-12-30Target: 60Updated: 2025-05-02

rhTPO Dose Escalation vs Eltrombopag Switch in ITP

Not yet recruitingNCT07476846

Institute of Hematology & Blood Diseases Hospital, ChinaPrimary Immune Thrombocytopenia (ITP)

Start: 2026-06-01End: 2028-03-01Target: 112Updated: 2026-07-01